AMERICAN INTERNATIONAL GROUP, INC. - VIR BIOTECHNOLOGY INC ownership

VIR BIOTECHNOLOGY INC's ticker is VIR and the CUSIP is 92764N102. A total of 206 filers reported holding VIR BIOTECHNOLOGY INC in Q1 2022. The put-call ratio across all filers is 0.66 and the average weighting 0.2%.

Quarter-by-quarter ownership
AMERICAN INTERNATIONAL GROUP, INC. ownership history of VIR BIOTECHNOLOGY INC
ValueSharesWeighting
Q3 2023$431,498
-60.5%
46,051
+3.4%
0.00%
-57.1%
Q2 2023$1,092,934
+18.0%
44,555
+11.9%
0.01%
+16.7%
Q1 2023$926,146
-7.7%
39,800
+0.4%
0.01%
-14.3%
Q4 2022$1,003,516
+30.3%
39,649
-0.7%
0.01%
+16.7%
Q3 2022$770,000
-23.3%
39,947
+1.4%
0.01%
-14.3%
Q2 2022$1,004,000
+30.7%
39,408
+32.0%
0.01%
+75.0%
Q1 2022$768,000
-42.6%
29,846
-6.6%
0.00%
-42.9%
Q4 2021$1,338,000
-6.6%
31,946
-2.9%
0.01%
-12.5%
Q3 2021$1,432,000
-10.1%
32,903
-2.3%
0.01%
+60.0%
Q2 2021$1,593,000
-0.5%
33,684
+7.9%
0.01%
-16.7%
Q1 2021$1,601,000
+92.0%
31,227
+0.3%
0.01%
+100.0%
Q4 2020$834,000
-24.2%
31,145
-2.8%
0.00%
-40.0%
Q3 2020$1,100,000
-5.2%
32,039
+13.1%
0.01%
-16.7%
Q2 2020$1,160,000
+694.5%
28,318
+564.0%
0.01%
+500.0%
Q1 2020$146,000
+156.1%
4,265
-5.5%
0.00%
Q4 2019$57,0004,5120.00%
Other shareholders
VIR BIOTECHNOLOGY INC shareholders Q1 2022
NameSharesValueWeighting ↓
Bill & Melinda Gates Foundation 1,559,142$40,100,00021.56%
SB INVESTMENT ADVISERS (UK) LTD 22,216,644$571,412,0002.71%
Nan Fung Group Holdings Ltd 210,563$5,416,0002.57%
Taikang Asset Management (Hong Kong) Co Ltd 533,332$13,717,0002.34%
Crawford Lake Capital Management, LLC 168,200$4,326,0001.80%
BOULDER HILL CAPITAL MANAGEMENT LP 126,900$3,264,0001.75%
Zebra Capital Management LLC 22,227$572,0001.31%
Alaska Permanent Fund Corp 2,300,000$59,156,0000.98%
CLARK ESTATES INC/NY 180,000$4,630,0000.73%
Temasek Holdings (Private) Ltd 5,602,553$144,097,6630.61%
View complete list of VIR BIOTECHNOLOGY INC shareholders